Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gohlke

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Hypertension (Dallas, Tex. : 1979)|January 1, 1994
Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in ratsP Albaladejo, H Bouaziz, M Duriez, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious ratsP Gohlke, S Weiss, A Jansen, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1995
Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitorsY C Zhu, H M Stauss, G Bao, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 1, 1992
Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive dosesP Gohlke, M Stoll, V Lamberty, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1992
Effect of early onset angiotensin converting enzyme inhibition on myocardial capillariesT Unger, T Mattfeldt, V Lamberty, et al.
Cardiovascular Research|December 21, 2000
Significance of timing of angiotensin AT1 receptor blockade in rats with myocardial infarction-induced heart failureQ G Xia, O Chung, H Spitznagel, et al.
Molecular and Cellular Biochemistry|June 7, 1995
Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosisW Linz, G Wiemer, J Schaper, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1993
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphateP Gohlke, V Lamberty, I Kuwer, et al.
European Journal of Pharmacology|December 23, 1999
Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarctionQ G Xia, O Chung, H Spitznagel, et al.
Journal of Hypertension|October 31, 1998
Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27H E Montgomery, L A Kiernan, C E Whitworth, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Hypertension (Dallas, Tex. : 1979)|January 1, 1994
Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in ratsP Albaladejo, H Bouaziz, M Duriez, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious ratsP Gohlke, S Weiss, A Jansen, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1995
Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitorsY C Zhu, H M Stauss, G Bao, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 1, 1992
Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive dosesP Gohlke, M Stoll, V Lamberty, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1992
Effect of early onset angiotensin converting enzyme inhibition on myocardial capillariesT Unger, T Mattfeldt, V Lamberty, et al.
Cardiovascular Research|December 21, 2000
Significance of timing of angiotensin AT1 receptor blockade in rats with myocardial infarction-induced heart failureQ G Xia, O Chung, H Spitznagel, et al.
Molecular and Cellular Biochemistry|June 7, 1995
Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosisW Linz, G Wiemer, J Schaper, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1993
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphateP Gohlke, V Lamberty, I Kuwer, et al.
European Journal of Pharmacology|December 23, 1999
Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarctionQ G Xia, O Chung, H Spitznagel, et al.
Journal of Hypertension|October 31, 1998
Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27H E Montgomery, L A Kiernan, C E Whitworth, et al.
Pageof 7